跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEPRAZ GASTRO RESISTANT TABLETS 20MG - HSA Drug Approval Details
Approvals
/
HSA
/
BEPRAZ GASTRO RESISTANT TABLETS 20MG
Approved
THERAPEUTIC
BEPRAZ GASTRO RESISTANT TABLETS 20MG
Sun Pharmaceutical Industries Limited
🇸🇬 Health Sciences Authority
Approval Date
Jun 7, 2017
Approval ID
84052d83ca1f11ec
Company
Sun Pharmaceutical Industries Limited
Type
Therapeutic
Approval Details
Approval Id
84052d83ca1f11ec
Drug Name
BEPRAZ GASTRO RESISTANT TABLETS 20MG
Product Name
BEPRAZ GASTRO RESISTANT TABLETS 20MG
Approval Number
SIN15259P
Approval Date
2017-06-07
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, DELAYED RELEASE
Route Of Administration
ORAL
Atc Code
A02BC04
Atc Item Name
rabeprazole
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Rabeprazole free base 18.85mg eqv Rabeprazole Sodium
20mg
RABEPRAZOLE FREE BASE 18.85 MG EQV RABEPRAZOLE SODIUM
20 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 7, 2017
Approval ID
84052d83ca1f11ec
Type
Therapeutic
Back to HSA Approvals